Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 852 of 1,261

  1. US 8536132

    Lymphatic zip codes in tumors and pre-malignant lesions

    The Regents of the University of California · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  2. US 8536195

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  3. US 8536133

    Selective high-affinity polydentate ligands and methods of making such

    The Regents of the University of California · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  4. US 8536148

    Disabling autophagy as a treatment for lysosomal storage diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  5. US 8536136

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  6. US 8536147

    Antibacterial antisense oligonucleotide and method

    Sarepta Therapeutics, Inc. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  7. US 8536149

    TRPM-2 antisense therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  8. US 8536363

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  9. US 8536206

    Process for the preparation of roflumilast

    TAKEDA GMBH · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  10. US 8536213

    Oligomer-dantrolene conjugates and related compounds

    Nektar Therapeutics · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  11. US 8536335

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance, Inc. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  12. US 8535890

    Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies

    The United of America as represented by the Secretary of the Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  13. US 8535667

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  14. US 8535687

    Smallpox DNA vaccine and the antigens therein that elicit an immune response

    Inovio Pharmaceuticals, Inc. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  15. US 8535712

    Radiation sensitive liposomes

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  16. US 8535656

    Amphiphilic polymer-protein conjugates and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  17. US 8535689

    Identification of bacterial autoinducer and use in treating bacterial pathogenicity

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  18. US 8535260

    Devices, systems, and methods for localized drug delivery

    Compass Therapeutics LLC · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  19. WO 2013133980

    DÉRIVÉS NITROXY DE STÉROÏDES DOUX

    BAUSCH & LOMB [US] · Granted Sep 12, 2013 · Expires Sep 7, 2033

    granted

  20. US 8530516

    Promoting cycling of ApoE4 isoform

    The Board of Regents of the University of Texas System · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  21. US 8530656

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  22. US 8530489

    5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  23. US 8530167

    Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  24. US 8529872

    Seeds and markers for use in imaging

    The Board of Regents of the University of Texas System · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.